Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS).
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
$substanceName is the active ingredient of these drugs:
Ecuador
Ecuador
Poland
Poland
Hong Kong
Estonia Lithuania
Austria
Australia Hong Kong
Finland Poland
Ecuador
Brazil
Ecuador
Brazil
Lithuania
Ireland
Australia Hong Kong
Cyprus Hong Kong
Poland
South Africa
Tunisia
South Africa
Cyprus
Germany
Brazil
Spain
Brazil
Canada Cyprus Ecuador Estonia France
Austria Finland South Africa
Singapore
Cyprus Hong Kong
Lithuania Poland
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):